Synthesis of Pyrrole Derivatives
FULL PAPER
117.4, 117.8, 119.5, 119.9, 129.8, 134.5, 138.0, 209.2 ppm. LRMS tBuLi (5.33 mL, 8 mmol) and ethyl cyclopropanecarboxylate
(70 eV, EI): m/z (%) ϭ 255 (14) [Mϩ], 184 (100). C17H21NO (255.4): (0.23 g, 2 mmol) at 20 °C overnight was followed by treatment with
calcd. C 79.96, H 8.29, N 5.49; found C 80.10, H 8.19, N 5.42.
DDQ (0.46 g, 2 mmol) in CH2Cl2 (20 mL) at 20 °C. Workup as
above yielded 10a (0.33 g, 65%) as a white solid. M.p. 132Ϫ134 °C.
1H NMR (200 MHz, CDCl3): δ ϭ 0.33Ϫ0.43 (m, 4 H), 1.05Ϫ1.23
(m, 1 H), 1.94 (br. s, 1 H), 2.24 (s, 3 H), 2.53 (d, J ϭ 15.6 Hz, 2
H), 2.73 (d, J ϭ 15.6 Hz, 2 H), 6.62 (s, 2 H), 7.01Ϫ7.15 (m, 4 H)
ppm. 13C NMR (50.3 MHz, CDCl3): δ ϭ 1.3, 19.5, 20.6, 39.1, 88.1,
111.8, 119.9, 128.5, 129.8, 134.4, 138.8 ppm. LRMS (70 eV, EI):
m/z (%) ϭ 253 (16) [Mϩ], 184 (100). C17H19NO (253.3): calcd. C
80.60, H 7.56, N 5.53; found C 80.48, H 7.47, N 5.50.
3-Methyl-4-(3-methyl-2-oxobutyl)-1-(4-methylphenyl)-1H-pyrrole
(9e): Amine 1a (0.69 g, 2 mmol) was treated at Ϫ78 °C with tBuLi
(5.33 mL of a 1.5 solution in pentane, 8 mmol) and ethyl isobu-
tyrate (0.27 mL, 2 mmol) for 1 h. Exposure of a CH2Cl2 (20 mL)
solution to the air and workup as above yielded 9e (0.40 g, 78%) as
a yellow oil. Rf ϭ 0.34 (hexane/EtOAc, 10:1). 1H NMR (200 MHz,
CDCl3): δ ϭ 1.02 (d, J ϭ 7.0 Hz, 6 H), 1.93 (s, 3 H), 2.22 (s, 3 H),
2.69 (hept, J ϭ 7.0 Hz, 1 H), 3.49 (s, 2 H), 6.70Ϫ6.74 (m, 1 H),
6.79Ϫ6.83 (m, 1 H), 7.02Ϫ7.15 (m, 4 H) ppm. 13C NMR
(50.3 MHz, CDCl3): δ ϭ 10.0, 18.3, 20.5, 37.7, 39.3, 117.2, 117.8,
119.4, 119.9, 129.8, 134.4, 138.2, 212.1 ppm. LRMS (70 eV, EI):
m/z (%) ϭ 255 (9) [Mϩ], 184 (100). C17H21NO (255.4): calcd. C
79.96, H 8.29, N 5.49; found C 79.80, H 8.39, N 5.46.
5-Methyl-2-(4-methylphenyl)-2,4,5,6-tetrahydrocyclopenta[c]pyrrol-
5-ol (10b): Treatment of amine 1a (0.69 g, 2 mmol) with tBuLi
(5.33 mL, 8 mmol) and EtOAc (0.20 mL, 2 mmol) at 20 °C over-
night was followed by treatment with DDQ (0.46 g, 2 mmol) in
CH2Cl2 (20 mL) at 20 °C. Workup as above yielded 10b (0.29 g,
64%) as a white solid. M.p. 140Ϫ142 °C. 1H NMR (200 MHz,
CDCl3): δ ϭ 1.54 (s, 3 H), 2.13 (br. s, 1 H), 2.25 (s, 3 H), 2.75 (d,
J ϭ 15.4 Hz, 2 H), 2.87 (d, J ϭ 15.4 Hz, 2 H), 6.74 (s, 2 H),
7.14Ϫ7.24 (m, 4 H) ppm. 13C NMR (50.3 MHz, CDCl3): δ ϭ 20.7,
27.4, 41.6, 86.2, 112.0, 120.1, 128.9, 129.9, 134.6, 138.8 ppm.
LRMS (70 eV, EI): m/z (%) ϭ 227 (16) [Mϩ], 184 (100). C15H17NO
(227.3): calcd. C 79.26, H 7.54, N 6.16; found C 79.21, H 7.45,
N 6.20.
3-Deuteriomethyl-4-(3-methyl-2-oxobutyl)-1-(4-methylphenyl)-1H-
pyrrole [9e(D)]: Amine 1a (0.69 g, 2 mmol) was treated at Ϫ78 °C
with tBuLi (5.33 mL of a 1.5 solution in pentane, 8 mmol) and
ethyl isobutyrate (0.27 mL, 2 mmol) for 1 h. The mixture was
quenched with MeOD. Exposure of a CH2Cl2 (20 mL) solution to
the air and workup as above yielded 9e(D) (0.38 g, 74%) as a yellow
oil. Rf ϭ 0.34 (hexane/EtOAc, 10:1). 1H NMR (400 MHz, CDCl3):
δ ϭ 1.12 (d, J ϭ 6.9 Hz, 6 H), 2.01Ϫ2.05 (m, 2 H), 2.35 (s, 3 H),
2.80 (hept, J ϭ 6.9 Hz, 1 H), 3.60 (s, 2 H), 6.82Ϫ6.84 (m, 1 H),
6.90Ϫ6.92 (m, 1 H), 7.16Ϫ7.24 (m, 4 H) ppm. 13C NMR
(100.6 MHz, CDCl3): δ ϭ 9.9 (t, JC/D ϭ 19.6 Hz), 18.4, 20.7, 37.8,
39.4, 117.3, 117.4, 117.9, 119.5, 119.9, 129.8, 134.5, 138.1, 212.1
ppm. LRMS (70 eV, EI): m/z (%) ϭ 256 (18) [Mϩ], 185 (100).
C17H21NO (255.4): calcd. C 79.65, H/D 8.65, N 5.46; found C
79.76, H/D 8.59, N 5.44.
5-Ethyl-2-(4-methylphenyl)-2,4,5,6-tetrahydrocyclopenta[c]pyrrol-5-
ol (10c): Amine 1a (0.69 g, 2 mmol) was treated at 20 °C with tBuLi
(5.33 mL of a 1.5 solution in pentane, 8 mmol) and ethyl propi-
onate (0.23 mL, 2 mmol) overnight. Exposure of a CH2Cl2 (20 mL)
solution to the air and workup as above yielded 10c (0.36 g, 75%)
as a clear brown solid. M.p. 126Ϫ128 °C. 1H NMR (200 MHz,
CDCl3): δ ϭ 1.04 (t, J ϭ 7.4 Hz, 3 H), 1.81 (q, J ϭ 7.4 Hz, 2 H),
2.06 (br. s, 1 H), 2.26 (s, 3 H), 2.67 (d, J ϭ 15.8 Hz, 2 H), 2.84 (d,
J ϭ 15.8 Hz, 2 H), 6.72 (s, 2 H), 7.11Ϫ7.25 (m, 4 H) ppm. 13C
NMR (50.3 MHz, CDCl3): δ ϭ 8.8, 20.7, 33.2, 39.5, 89.3, 112.0,
120.0, 128.8, 129.8, 134.5, 138.9 ppm. LRMS (70 eV, EI): m/z
(%) ϭ 241 (24) [Mϩ], 184 (100). C16H19NO (241.3): calcd. C 79.63,
H 7.94, N 5.80; found C 79.74, H 7.99, N 5.72.
3-Methyl-1-(4-methylphenyl)-4-(2-oxo-2-phenylethyl)-1H-pyrrole
(9f): Treatment of amine 1a (0.69 g, 2 mmol) at Ϫ78 °C with tBuLi
(5.33 mL, 8 mmol) and ethyl benzoate (0.30 g, 2 mmol) for 1 h was
followed by treatment with DDQ (0.46 g, 2 mmol) in CH2Cl2
(20 mL) at 20 °C. Workup as above yielded 9f (0.40 g, 69%) as a
1
reddish solid. M.p. 82Ϫ84 °C. H NMR (200 MHz, CDCl3): δ ϭ
2.00 (s, 3 H), 2.23 (s, 3 H), 4.04 (s, 2 H), 6.73Ϫ6.77 (m, 1 H),
6.79Ϫ6.83 (m, 1 H), 7.00Ϫ7.15 (m, 4 H), 7.30Ϫ7.51 (m, 3 H),
7.92Ϫ7.99 (m, 2 H) ppm. 13C NMR (50.3 MHz, CDCl3): δ ϭ 10.3,
20.7, 35.7, 117.3, 117.4, 118.0, 119.5, 120.0, 128.4, 128.5, 129.8,
132.8, 134.5, 136.7, 138.1, 197.9 ppm. LRMS (70 eV, EI): m/z
(%) ϭ 289 (14) [Mϩ], 184 (100). C20H19NO (289.4): calcd. C 83.01,
H 6.62, N 4.84; found C 82.87, H 6.55, N 4.88.
2-(4-Methylphenyl)-5-propyl-2,4,5,6-tetrahydrocyclopenta[c]pyrrol-
5-ol (10d): Treatment of amine 1a (0.69 g, 2 mmol) at 20 °C with
tBuLi (5.33 mL, 8 mmol) and ethyl butyrate (0.27 mL, 2 mmol)
overnight, was followed by treatment with DDQ (0.46 g, 2 mmol)
in CH2Cl2 (20 mL) at 20 °C. Workup as above yielded 10d (0.35 g,
68%) as a pale yellow solid. M.p. 98Ϫ100 °C. 1H NMR (200 MHz,
CDCl3): δ ϭ 0.88 (t, J ϭ 7.1 Hz, 3 H), 1.32Ϫ1.55 (m, 2 H),
1.60Ϫ1.73 (m, 2 H), 2.03 (br. s, 1 H), 2.24 (s, 3 H), 2.59 (d, J ϭ
15.5 Hz, 2 H), 2.75 (d, J ϭ 15.5 Hz, 2 H), 6.63 (s, 2 H), 7.02Ϫ7.16
(m, 4 H) ppm. 13C NMR (50.3 MHz, CDCl3): δ ϭ 14.6, 17.8, 20.6,
40.0, 43.0, 88.9, 111.9, 120.0, 128.8, 129.8, 134.4, 138.8 ppm.
LRMS (70 eV, EI): m/z (%) ϭ 255 (13) [Mϩ], 184 (100). C17H21NO
(255.4): calcd. C 79.96, H 8.29, N 5.49; found C 80.10, H 8.33,
N 5.42.
3-(6-Bromo-2-oxohexyl)-4-methyl-1-(4-methylphenyl)-1H-pyrrole
(16): Treatment of amine 1a (0.69 g, 2 mmol) at Ϫ78 °C with tBuLi
(5.33 mL, 8 mmol) and ethyl 5-bromovalerate (0.42 g, 2 mmol) for
1 h, was followed by exposure of a CH2Cl2 (20 mL) solution to the
air at 20 °C. Workup as above yielded 16 (0.48 g, 69%) as a color-
less oil. Rf ϭ 0.20 (hexane/EtOAc, 10:1). 1H NMR (400 MHz,
CDCl3): δ ϭ 1.59Ϫ1.68 (m, 2 H), 1.69Ϫ1.78 (m, 2 H), 1.95 (s, 3
H), 2.26 (s, 3 H), 2.43 (t, J ϭ 7.2 Hz, 2 H), 3.27 (t, J ϭ 6.6 Hz, 2
H), 3.44 (s, 2 H), 6.74Ϫ6.76 (m, 1 H), 6.81Ϫ6.83 (m, 1 H),
7.06Ϫ7.16 (m, 4 H) ppm. 13C NMR (100.6 MHz, CDCl3): δ ϭ
10.1, 20.7, 22.2, 31.9, 32.2, 40.0, 40.1, 117.1, 117.4, 117.8, 119.5,
119.9, 129.9, 134.7, 138.0, 208.5 ppm. LRMS (70 eV, EI): m/z
(%) ϭ 349 (4) [Mϩ ϩ 2], 347 (4) [Mϩ], 184 (100). C18H22BrNO
(348.3): calcd. C 62.07, H 6.37, N 4.02; found C 62.15, H 6.28,
N 3.99.
5-Isopropyl-2-(4-methylphenyl)-2,4,5,6-tetrahydrocyclopenta[c]-
pyrrol-5-ol (10e): Amine 1a (0.69 g, 2 mmol) was treated at 20 °C
with tBuLi (5.33 mL of a 1.5 solution in pentane, 8 mmol) and
ethyl isobutyrate (0.27 mL, 2 mmol) overnight. Exposure of a
CH2Cl2 solution (20 mL) to the air and workup as above yielded
10e (0.39 g, 77%) as a yellowish solid. M.p. 115Ϫ117 °C. 1H NMR
(200 MHz, CDCl3): δ ϭ 0.97 (d, J ϭ 6.9 Hz, 6 H), 1.72 (br. s, 1
H), 1.89 (hept, J ϭ 6.9 Hz, 1 H), 2.27 (s, 3 H), 2.58 (d, J ϭ 15.6 Hz,
5-Cyclopropyl-2-(4-methylphenyl)-2,4,5,6-tetrahydrocyclopenta[c]- 2 H), 2.81 (d, J ϭ 15.6 Hz, 2 H), 6.68 (s, 2 H), 7.06Ϫ7.20 (m, 4 H)
pyrrol-5-ol (10a): Treatment of amine 1a (0.69 g, 2 mmol) with ppm. 13C NMR (50.3 MHz, CDCl3): δ ϭ 17.6, 20.6, 36.7, 38.6,
Eur. J. Org. Chem. 2003, 771Ϫ783
779